|
|
 |
CHINA-BRITAIN-CORRUPTION-PHARMACEUTICAL-GSK
The China headquarters of British company AstraZenica is seen in the Zhangjiang district of Shanghai on July 24, 2013. Beijing's targeting of British pharmaceutical giant GlaxoSmithKline (GSK) in a high-profile bribery probe is a reminder of the risks foreign companies face when seeking the huge rewards of China's market, analysts say. Police say GSK staff offered government officials and doctors bribes, and took kick-backs from travel agencies to organise conferences, some of which were fake. Chinese authorities have also questioned three Shanghai-based employees of Britain's AstraZeneca, detaining two, and have visited the offices of Belgium's UCB, according to the companies, although they did not specify what was being investigated. CHINA OUT AFP PHOTO
|
|
|
|
Detalii fotografie |
| Loc: |
|
Shanghai, CHINA |
|
| Sursa: |
|
AFP / Mediafax Foto |
|
| Fotograf: |
|
STR |
|
| Data: |
|
24 Iulie 2013 |
|
| Dimensiuni: |
|
3482 x 2322 (1.01 MB) |
|
|
|
|
|
|